The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Disaggregation of Alzheimer β-amyloid by site-directed mAb
Open accessAbstract
In Alzheimer disease, β-amyloid peptide accumulates in the brain as insoluble amyloid plaques. Amyloid filaments, similar to those found in amyloid plaques, can be assembled in vitro from chemically synthesized β-peptides. In this study, we report that antibodies raised against the N-terminal region (1–28) of the β-amyloid peptide bind to the in vitro-formed β-amyloid assemblies, leading to disaggregation of the fibrils and partial restoration of the peptide’s solubility. The concomitant addition of fibrillar β-amyloid with these antibodies to PC 12 cells leads to the inhibition of the neurotoxic effects of β-amyloid. Some of the mAbs raised against soluble β-peptide (1–28) have been found to prevent in vitro fibrillar aggregation of β-amyloid peptide. These experimental data suggest that site-directed mAbs interfere with the aggregation of β-amyloid and trigger reversal to its nontoxic, normal components. The above findings give hints on how to convert in vivo senile plaques into nontoxic, diffuse components and may have therapeutic interest for those studying Alzheimer disease and other human diseases related to amyloidogenic properties of physiological peptides and proteins.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hansen, M. B., Nielsen, S. E., & Berg, K. (1989) · Journal of Immunological Methods · doi:10.1016/0022-1759(89)90397-9 · Cited by 3,507
Levine, H. (1993) · Protein Science · doi:10.1002/pro.5560020312 · Cited by 2,264
Jarrett, J. T., & Lansbury, P. T. (1993) · Cell · doi:10.1016/0092-8674(93)90635-4 · Cited by 2,178
Neurotrophic and Neurotoxic Effects of Amyloid β Protein: Reversal by Tachykinin Neuropeptides
Yankner, B. A., Duffy, L. K., & Kirschner, D. A. (1990) · Science · doi:10.1126/science.2218531 · Cited by 1,975
Amyloid β-peptide is produced by cultured cells during normal metabolism
Haass, C., Schlossmacher, M. G., Hung, A. Y., Vigo-Pelfrey, C., Mellon, A., Ostaszewski, B. L., Lieberburg, I., Koo, E. H., Schenk, D., Teplow, D. B., et al. (1992) · Nature · doi:10.1038/359322a0 · Cited by 1,921
Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids
Seubert, P., Vigo-Pelfrey, C., Esch, F., Lee, M., Dovey, H., Davis, D., Sinha, S., Schiossmacher, M., Whaley, J., Swindlehurst, C., et al. (1992) · Nature · doi:10.1038/359325a0 · Cited by 1,731
Production of the Alzheimer Amyloid β Protein by Normal Proteolytic Processing
Shoji, M., Golde, T. E., Ghiso, J., Cheung, T. T., Estus, S., Shaffer, L. M., Cai, X.-D., McKay, D. M., Tintner, R., Frangione, B., et al. (1992) · Science · doi:10.1126/science.1439760 · Cited by 1,447
Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state
Pike, C., Burdick, D., Walencewicz, A., Glabe, C., & Cotman, C. (1993) · The Journal of Neuroscience · doi:10.1523/jneurosci.13-04-01676.1993 · Cited by 1,417
Cleavage of Amyloid β Peptide During Constitutive Processing of Its Precursor
Esch, F. S., Keim, P. S., Beattie, E. C., Blacher, R. W., Culwell, A. R., Oltersdorf, T., McClure, D., & Ward, P. J. (1990) · Science · doi:10.1126/science.2111583 · Cited by 1,410
Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red.
Lorenzo, A., & Yankner, B. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.25.12243 · Cited by 1,324
Three-Dimensional Structure of an Antigen-Antibody Complex at 2.8 Å Resolution
Amit, A. G., Mariuzza, R. A., Phillips, S. E. V., & Poljak, R. J. (1986) · Science · doi:10.1126/science.2426778 · Cited by 1,182
Molecular dynamics simulations in biology
Karplus, M., & Petsko, G. A. (1990) · Nature · doi:10.1038/347631a0 · Cited by 1,152
Temperature-dependent X-ray diffraction as a probe of protein structural dynamics
Frauenfelder, H., Petsko, G. A., & Tsernoglou, D. (1979) · Nature · doi:10.1038/280558a0 · Cited by 1,149
Neurotoxicity of a prion protein fragment
Forloni, G., Angeretti, N., Chiesa, R., Monzani, E., Salmona, M., Bugiani, O., & Tagliavini, F. (1993) · Nature · doi:10.1038/362543a0 · Cited by 943
Saido, T. C., Iwatsubo, T., Mann, D. M. A., Shimada, H., Ihara, Y., & Kawashima, S. (1995) · Neuron · doi:10.1016/0896-6273(95)90301-1 · Cited by 587
Aggregation and secondary structure of synthetic amyloid βA4 peptides of Alzheimer's disease
Hilbich, C., Kisters-Woike, B., Reed, J., Masters, C. L., & Beyreuther, K. (1991) · Journal of Molecular Biology · doi:10.1016/0022-2836(91)90881-6 · Cited by 580
Interactions of protein antigens with antibodies.
Davies, D. R., & Cohen, G. H. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.1.7 · Cited by 550
Solution Structures of β Peptide and Its Constituent Fragments: Relation to Amyloid Deposition
Barrow, C. J., & Zagorski, M. G. (1991) · Science · doi:10.1126/science.1853202 · Cited by 537
Kirschner, D. A., Inouye, H., Duffy, L. K., Sinclair, A., Lind, M., & Selkoe, D. J. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.19.6953 · Cited by 482
Physiological production of the β-amyloid protein and the mechanism of Alzheimer's disease
Selkoe, D. J. (1993) · Trends in Neurosciences · doi:10.1016/0166-2236(93)90008-a · Cited by 424
Shearman, M. S., Ragan, C. I., & Iversen, L. L. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.4.1470 · Cited by 412
Monoclonal antibodies inhibit in vitro fibrillar aggregation of the Alzheimer beta-amyloid peptide.
Solomon, B., Koppel, R., Hanan, E., & Katzav, T. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.1.452 · Cited by 316
Self-citationAmino-terminal Deletions Enhance Aggregation of β-Amyloid Peptides in Vitro
Pike, C. J., Overman, M. J., & Cotman, C. W. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.41.23895 · Cited by 302
Halverson, K., Fraser, P. E., Kirschner, D. A., & Lansbury, P. T. (1990) · Biochemistry · doi:10.1021/bi00463a003 · Cited by 292
Inouye, H., Fraser, P. E., & Kirschner, D. A. (1993) · Biophysical Journal · doi:10.1016/s0006-3495(93)81393-6 · Cited by 278
Surfactant properties of Alzheimer's A beta peptides and the mechanism of amyloid aggregation.
Soreghan, B., Kosmoski, J., & Glabe, C. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)61939-3 · Cited by 267
Small rearrangements in structures of Fv and Fab fragments of antibody D 1.3 on antigen binding
Bhat, T. N., Bentley, G. A., Fischmann, T. O., Boulot, G., & Poljak, R. J. (1990) · Nature · doi:10.1038/347483a0 · Cited by 250
Gowing, E., Roher, A. E., Woods, A. S., Cotter, R. J., Chaney, M., Little, S. P., & Ball, M. J. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)78080-6 · Cited by 223
Aggregation State and Neurotoxic Properties of Alzheimer Beta-Amyloid Peptide
Howlett, D. R., Jennings, K. H., Lee, D. C., Clark, M. S. G., Brown, F., Wetzel, R., Wood, S. J., Camilleri, P., & Roberts, G. W. (1995) · Neurodegeneration · doi:10.1006/neur.1995.0003 · Cited by 204
Shearman, M. S., Hawtin, S. R., & Tailor, V. J. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.65010218.x · Cited by 203
Prion Protein Peptides Induce .alpha.-Helix to .beta.-Sheet Conformational Transitions
Nguyen, J., Baldwin, M. A., Cohen, F. E., & Prusiner, S. B. (1995) · Biochemistry · doi:10.1021/bi00013a006 · Cited by 193
Rifampicin Prevents the Aggregation and Neurotoxicity of Amyloid β Protein in Vitro
Tomiyama, T., Asano, S., Suwa, Y., Morita, T., Kataoka, K., Mori, H., & Endo, N. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.2428 · Cited by 158
Fraser, P. E., Nguyen, J. T., McLachlan, D. R. C., Abraham, C. R., & Kirschner, D. A. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb03568.x · Cited by 148
Hyman, B. T., Tanzi, R. E., Marzloff, K., Barbour, R., & Schenk, D. (1992) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199201000-00009 · Cited by 135
May, P. C., Boggs, L. N., & Fuson, K. S. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb07480.x · Cited by 131
Morphology and antibody recognition of synthetic β‐amyloid peptides
Fraser, P. E., Duffy, L. K., O'Malley, M. B., Nguyen, J. T., Inouye, H., & Kirschner, D. A. (1991) · Journal of Neuroscience Research · doi:10.1002/jnr.490280404 · Cited by 98
Goldfarb, L. G., Brown, P., Haltia, M., Ghiso, J. A., Frangione, B., & Gajdusek, D. C. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.10.4451 · Cited by 53
Antibody Assisted Protein Refolding
Carlson, J. D., & Yarmush, M. L. (1992) · Nature Biotechnology · doi:10.1038/nbt0192-86 · Cited by 52
Calretinin-immunoreactive neurons are resistant to β-amyloid toxicity in vitro
Pike, C. J., & Cotman, C. W. (1995) · Brain Research · doi:10.1016/0006-8993(94)01354-k · Cited by 52
Chaperone‐like effect of monoclonal antibodies on refolding of heat‐denatured carboxypeptidase A
Solomon, B., & Schwartz, F. (1995) · Journal of Molecular Recognition · doi:10.1002/jmr.300080113 · Cited by 32
Self-citationEffect of monoclonal antibodies in preventing carboxypeptidase A aggregation
Katzav-Gozansky, T., Hanan, E., & Solomon, B. (1996) · Biotechnology and Applied Biochemistry · doi:10.1111/j.1470-8744.1996.tb00380.x · Cited by 30
Self-citationInhibitory effect of monoclonal antibodies on Alzheimer's β-amyloid peptide aggregation
Hanan, E., & Solomon, B. (1996) · Amyloid · doi:10.3109/13506129609014365 · Cited by 6
Self-citation
Cited by
In vitro characterization of conditions for amyloid-β peptide oligomerization and fibrillogenesis
Stine, W. B., Dahlgren, K. N., Krafft, G. A., & LaDu, M. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210207200 · Cited by 1,015
The Amyloid Beta Peptide: A Chemist’s Perspective. Role in Alzheimer’s and Fibrillization
Hamley, I. W. (2012) · Chemical Reviews · doi:10.1021/cr3000994 · Cited by 882
Alzheimer's Disease: Molecular Understanding Predicts Amyloid-Based Therapeutics
Selkoe, D. J., & Schenk, D. (2003) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.43.100901.140248 · Cited by 818
Single‐domain antibody fragments with high conformational stability
Dumoulin, M., Conrath, K., Van Meirhaeghe, A., Meersman, F., Heremans, K., Frenken, L. G. J., Muyldermans, S., Wyns, L., & Matagne, A. (2002) · Protein Science · doi:10.1110/ps.34602 · Cited by 638
Islet Amyloid and Type 2 Diabetes Mellitus
Höppener, J. W. M., Ahrén, B., & Lips, C. J. M. (2000) · New England Journal of Medicine · doi:10.1056/nejm200008103430607 · Cited by 521
Metadata
- Authors
- Solomon, B., Koppel, R., Frankel, D., & Hanan-Aharon, E.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1997-04-15
- Volume
- 94
- Issue
- 8
- Pages
- 4109-4112
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2039716280
- Cited by
- 421
- References
- 42
- FWCI
- 4.02
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.